Skip to main content

Table 5 Subjects parameters changes

From: Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial

Variable Tocotrienols (n = 30) Placebo (n = 34) PValue (Tocotrienols vs Placebo)
BMI (kg/m2) -0.6 -0.3 0.527
TC (mmol/L) -0.3 -0.2 0.055
HDL (mmol/L) -0.04 0.02 0.778
LDL (mmol/L) -0.2 -0.1 0.052
TG (mmol/L) -0.2 -0.2 0.814
ALP (IU/L) -7.0 1.4 0.471
AST (IU/L) -4.8 -3.4 0.207
ALT (IU/L) -5.9 -0.6 0.118
GGT (IU/L) -1.4 -4.2 0.364
C-rp (mg/L) -0.2 -0.2 0.835
Apo B (g/L) -0.01 -0.03 0.046
Lp(A) (mg/dL) 2.3 0.4 0.524
Serum creatinine (μmol/L) -5.1 -1.9 0.524
Fasting glucose (mmol/L) 0.5 0.5 0.490
Systolic (mmHg) 0.1 0.6 0.660
Diastolic (mmHg) -0.3 -2.4 0.607
  1. Mean changes in anthropometric and laboratory parameters for the study subjects after 1 year of treatment. P < 0.05 is considered significant.
  2. [ANOVA for split-plot design adjusted for unweighted means; Numbers’09].
  3. Abbreviations as in Table 2 .